LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 962 | 7221 | 10641 | 0.6786 | 0.7884 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 962 | 10613 | 10714 | 0.9906 | 0.9946 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 962 | 10906 | 10507 | 1.0379 | 1.0217 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 962 | 10582 | 10315 | 1.0259 | 1.0150 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 962 | 10487 | 10714 | 0.9788 | 0.9877 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 962 | 10635 | 10507 | 1.0121 | 1.0070 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 962 | 10184 | 10315 | 0.9873 | 0.9925 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 962 | 9849 | 10714 | 0.9193 | 0.9522 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 962 | 9965 | 10507 | 0.9483 | 0.9695 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 962 | 9555 | 10315 | 0.9263 | 0.9558 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 962 | 9111 | 10714 | 0.8504 | 0.9089 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 962 | 9313 | 10507 | 0.8863 | 0.9312 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 962 | 8866 | 10315 | 0.8595 | 0.9135 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 962 | 7943 | 10714 | 0.7414 | 0.8351 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 962 | 8298 | 10507 | 0.7897 | 0.8677 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 962 | 7704 | 10315 | 0.7469 | 0.8365 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 1 | A19 | 72 | hr | 962 | 1318 | 10714 | 0.1230 | 0.0947 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 2 | A19 | 72 | hr | 962 | 1421 | 10507 | 0.1352 | 0.1197 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 3 | A19 | 72 | hr | 962 | 1438 | 10315 | 0.1394 | 0.1246 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 1 | D06 | 72 | hr | 962 | 10559 | 10693 | 0.9874 | 0.9927 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 2 | D06 | 72 | hr | 962 | 10605 | 10740 | 0.9874 | 0.9927 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 3 | D06 | 72 | hr | 962 | 10272 | 10641 | 0.9653 | 0.9797 |
MCF 10A | BMS345541 | 0.12 | uM | LJP6 | 1 | D05 | 72 | hr | 962 | 10458 | 10693 | 0.9780 | 0.9872 |
MCF 10A | BMS345541 | 0.12 | uM | LJP6 | 2 | D05 | 72 | hr | 962 | 10386 | 10740 | 0.9670 | 0.9808 |
MCF 10A | BMS345541 | 0.12 | uM | LJP6 | 3 | D05 | 72 | hr | 962 | 9827 | 10641 | 0.9235 | 0.9546 |